Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008

Delgermaa, Vanya; Takahashi, Ken; Park, Eun-Kee; Le, Giang Vinh; Hara, Toshiyuki; Sorahan, Tom

doi:10.2471/blt.11.086678

Cited by 331 publications

(319 citation statements)

References 27 publications

Supporting

Mentioning

289

Contrasting

Unclassified

Order By: Relevance

“…According to the World Health Organization (WHO) data between 1994 and 2008, 92,253 deaths related to MPM have been recorded. 78% of the patients were male and 22% female [4]. The death rate of MPM may vary in each country [3,8].…”

Section: Epidemiologymentioning

confidence: 99%

“…88,1% of MPM deaths were recorded in the developed, high income countries and only 11,82% in the middle and low income country group. The country with the majority of MPM deaths between 1994 and 2008 was the United States (US) [4]. Between 2003 and 2008 19,011 cases of MPM were documented.…”

Section: Epidemiologymentioning

confidence: 99%

“…[3] According to WHO, the United Kingdom (UK) follows, having 14,6% of MPM deaths worldwide. [4] Despite having banned the import of asbestos for two decades into the UK, Health and Safety Executive data for 2012 show that MPM caused 2535 deaths in England, Wales and Scotland [13]. According to the WHO list with the top ten countries with MPM deaths between 1994 and 2008, Japan follows further with a percentage of 12,1%, Germany with 10,4% and France with 7,2%.…”

Section: Epidemiologymentioning

confidence: 99%

“…Mesothelioma arises from the pleura in 70-90% [1][2][3][4] and from the peritoneum in 10-30% of the cases [5]. Rarely it can arise from testicles (<1%) [6] or the pericardium (<1%) [7].…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Malignant Pleura Mesothelioma: Clinical Perspectives

Grapatsas¹,

Leivaditis²,

Dahm³

et al. 2017

Oncomedicine

View full text Add to dashboard Cite

Malignant pleural mesothelioma (MPM) is a primary health issue which preoccupies the health professional community worldwide. The main cause of the disease is the environmental exposure to asbestos. Because of the lack of relevant symptomatology, the disease is usually diagnosed at an advanced stage. Despite the progress in the therapeutic means, the mortality of the disease remains high. Τhe optimal approach to the disease consists of the preventive efforts to remove asbestos materials, the early diagnosis and proper early therapeutic treatment. Despite the fact that new cases of MPM are diagnosed, it is believed that the incidence of the disease is declining. In this study an overview of the epidemiology, etiology, mechanisms of pathophysiology and symptomatology of MPM is carried out.

show abstract

Section: Epidemiologymentioning

confidence: 99%

Section: Epidemiologymentioning

confidence: 99%

Section: Epidemiologymentioning

confidence: 99%

“…Mesothelioma arises from the pleura in 70-90% [1][2][3][4] and from the peritoneum in 10-30% of the cases [5]. Rarely it can arise from testicles (<1%) [6] or the pericardium (<1%) [7].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Malignant Pleura Mesothelioma: Clinical Perspectives

Grapatsas¹,

Leivaditis²,

Dahm³

et al. 2017

Oncomedicine

View full text Add to dashboard Cite

show abstract

“…During the last decades, malignant mesothelioma, once a very rare entity, showed an impressive rise in incidence in various countries Delgermaa et al, 2011;Park et al, 2011). Mesothelioma incidence/mortality shows extreme variations from one country to another .…”

Section: Introductionmentioning

confidence: 99%

Malignant Mesothelioma in Eastern Asia

Bianchi¹,

Bianchi²

2012

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

Relatively low numbers of malignant mesotheliomas have been reported from Eastern Asia. In order to explore the causes of this fact, the available data on mesothelioma incidence/mortality in five countries (Japan, South Korea, Taiwan, Hong Kong, and Singapore) were reviewed. Data on the industrial histories of the above countries were also examined. Mesothelioma incidence was low, despite a history of high shipbuilding and port activities, in which heavy exposure to asbestos generally has occurred. Underestimation of mesothelioma could partly explain the above discrepancy. Moreover, in some areas a sufficient latency period for mesothelioma development may have not yet elapsed, due to recent industrialization. However, other possibilities have to be considered. The cancer epidemiology in Eastern Asia differs deeply from that seen in Western countries, an indication of differences in etiologic factors of cancer as well as in co-factors. In addition, the oncogenic spectrum of asbestos is wide, and not completely defined. In a very different milieu from that of Western countries, asbestos could preferentially hit targets other than serosal membranes.

show abstract

Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017

et al. 2021

View full text Add to dashboard Cite

Key Points Question What are the temporal trends and epidemiological distribution of mesothelioma, and have cases of mesothelioma increased worldwide since 1990? Findings In this cross-sectional study of 21 regions comprising 195 countries and territories, global mesothelioma cases continuously increased, with more than 50% of cases recorded in regions with high sociodemographic index levels; in recent years, incidence and mortality also increased, especially among female individuals, in regions with low sociodemographic index levels. Meaning This study found that incident mesothelioma cases and deaths associated with mesothelioma have continuously increased worldwide, especially in resource-limited regions in which a complete and immediate ban on asbestos use may be warranted.

show abstract

Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008

Abstract: ResearchGlobal mesothelioma mortality Vanya Delgermaa et al.

Cited by 331 publications

References 27 publications

Malignant Pleura Mesothelioma: Clinical Perspectives

Malignant Pleura Mesothelioma: Clinical Perspectives

Malignant Mesothelioma in Eastern Asia

Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017

Contact Info

Product

Resources

About